FMR LLC Acquires Significant Stake in Verona Pharma PLC
VRNA Stock | USD 67.53 4.21 6.65% |
About 54% of Verona Pharma's investors are presently thinking to get in. The analysis of overall sentiment of trading Verona Pharma PLC stock suggests that some investors are interested at this time. The current market sentiment, together with Verona Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Verona Pharma PLC stock news signals to limit their universe of possible portfolio assets.
Overview of the Recent Transaction On November 8, 2024, FMR LLC , a prominent investment firm, executed a significant transaction by acquirin
Read at gurufocus.com
![]() |
Verona Pharma Fundamental Analysis
We analyze Verona Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Verona Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Verona Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Verona Pharma is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Verona Pharma PLC Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Verona Pharma stock to make a market-neutral strategy. Peer analysis of Verona Pharma could also be used in its relative valuation, which is a method of valuing Verona Pharma by comparing valuation metrics with similar companies.
Peers
Verona Pharma Related Equities
PTGX | Protagonist Therapeutics | 5.35 | ||||
IDYA | Ideaya Biosciences | 5.34 | ||||
VKTX | Viking Therapeutics | 2.72 | ||||
SNDX | Syndax Pharmaceuticals | 2.71 | ||||
INZY | Inozyme Pharma | 2.61 | ||||
MDGL | Madrigal Pharmaceuticals | 2.08 | ||||
APLS | Apellis Pharmaceuticals | 1.27 | ||||
AMLX | Amylyx Pharmaceuticals | 0.22 | ||||
MREO | Mereo BioPharma | 0.41 | ||||
TERN | Terns Pharmaceuticals | 0.66 | ||||
XFOR | X4 Pharmaceuticals | 0.89 | ||||
ABOS | Acumen Pharmaceuticals | 2.00 | ||||
VTYX | Ventyx Biosciences | 2.42 | ||||
MLTX | MoonLake Immunotherapeuti | 3.20 | ||||
DAWN | Day One | 4.59 | ||||
AKRO | Akero Therapeutics | 5.99 |
Complementary Tools for Verona Stock analysis
When running Verona Pharma's price analysis, check to measure Verona Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verona Pharma is operating at the current time. Most of Verona Pharma's value examination focuses on studying past and present price action to predict the probability of Verona Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verona Pharma's price. Additionally, you may evaluate how the addition of Verona Pharma to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |